Is Imposter Syndrome Real? What Actually Helps

Direct answer: Imposter syndrome, first named by psychologists Pauline Clance and Suzanne Imes in 1978, is a real, well-documented pattern where people attribute their success to luck or effort rather than ability, and sometimes hold themselves back from further success to avoid being “found out.” But a systematic review found no clinical trials have ever tested a treatment specifically for it, so most advice claiming to “fix” it isn’t backed by the evidence it implies.

Where the Idea Actually Comes From

Clance and Imes coined the term in 1978 after observing a pattern in high-achieving women: despite real, external evidence of competence, degrees, awards, promotions, they privately believed they were frauds who had somehow fooled everyone around them. The two researchers later developed the Clance Impostor Phenomenon Scale (CIPS), a 20-item, validated questionnaire that measures how strongly someone attributes their success to external causes and dreads being exposed as incompetent, which is still the standard tool used in research today.

A specific, less-discussed part of Clance and Imes’s original observation is directly relevant to the “why do I sabotage my own success” question: they described people who felt driven to work hard while simultaneously avoiding the next step toward visible success, out of fear that more success would only raise the stakes of eventually being unmasked. That’s a real, named contradiction in the original research, not just a modern self-help reframing: fear of success and fear of failure were both identified as preconditions that feed the same underlying pattern.

How Common It Actually Is (The Honest Range)

A systematic review of imposter-syndrome research found reported prevalence ranging from 9% to 82% across different studies, an unusually wide range that depends heavily on which screening tool was used, how strict the symptom cutoff was, and who was recruited into the study. That range itself is worth sitting with: it means any single “X% of people have imposter syndrome” statistic quoted without its source and methodology is close to meaningless on its own, since the true figure swings by a factor of nine depending on how you ask the question.

Here is the finding most likely to surprise a reader used to confident “how to cure imposter syndrome” content: the same systematic review found that no clinical trials have ever tested a treatment designed specifically for imposter syndrome. That’s a genuine, current gap in the evidence, not a minor caveat. What the review’s authors recommend instead is more modest and more honest: screen for depression and anxiety, which commonly occur alongside imposter feelings, and treat those with therapies that do have a real evidence base; consider peer-group settings where people can discuss self-doubt out loud, since isolation tends to make the feeling worse; and, in workplaces, build cultures with real mentoring and where mistakes aren’t treated as catastrophic failures.

The honest takeaway for a family: the feeling is real, named, and measurable, and the fear-of-success pattern behind stalling right before a breakthrough is a genuinely documented part of the original research, not an invented marketing hook. But anyone promising a proven method to eliminate it is describing something the research itself doesn’t yet support, which is a meaningfully different claim from “this feeling is common and there are reasonable things that help alongside it.”

Sources: Clance, P.R. & Imes, S.A. (1978), “The Impostor Phenomenon in High Achieving Women: Dynamics and Therapeutic Intervention,” Psychotherapy: Theory, Research & Practice, for the original naming of the phenomenon, the fear-of-success/fear-of-failure preconditions, and the Clance Impostor Phenomenon Scale (CIPS). “Prevalence, Predictors, and Treatment of Imposter Syndrome: A Systematic Review,” Mental Health Journal (mentalhealthjournal.org/articles/commentary-prevalence-predictors-and-treatment-of-imposter-syndrome-a-systematic-review.html), for the 9%-82% prevalence range across studies and the finding that no clinical trials have tested a treatment specifically for imposter syndrome, plus the review’s recommended interim approaches (comorbidity screening, peer support, workplace culture). Verified imposter-syndrome research against these sources on 2026-08-03.